Article
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.
JCO global oncology - 1 Aug 2022
Riva Eloísa, Duarte Patricio José, Valcárcel Bryan, Remaggi Guillermina, Murrieta Ivan, Corzo Ariel, Del Carpio Daniel, Peña Camila, Vásquez Jule, Bove Virginia, Teixeira Larissa, Fleury-Perini Guilherme, Yantorno Sebastian, Samánez César, Lopresti Sergio, Altamirano Milagros, Villela Luis, Ruiz-Arguelles Guillermo J, Ruiz-Delgado Guillermo J, Montaño Efreen, Verri Verónica, Zamora Pérez Elia, Pérez Jacobo Fernando, Idrobo Henry, Martínez-Cordero Humberto, Beltran Brady E, Ramírez Jhoanna, Castillo Jorge J, Malpica Castillo Luis E
Abstract excerpt
PURPOSE: Waldenstrom Macroglobulinemia (WM) is a rare lymphoma with distinct clinical features, and data from Latin American patients are lacking. Therefore, we aim to investigate the clinical, therapy, and outcome patterns of WM in Latin America. METHODS: We retrospectively analyzed patients with WM diagnosed between 1991 and 2019 from 24 centers in seven Latin American countries. The study outcomes were overall...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.